Drug-induced optic neuritis and uveitis secondary to bisphosphonates.
Stack
Rebecca
R
Ophthalmology Department, Christchurch Hospital, Christchurch, New Zealand. docbecs@hotmail.com
Tarr
Kenneth
K
D000368:Aged; D050071:Bone Density Conservation Agents / Q000009:adverse effects*; D004164:Diphosphonates / Q000009:adverse effects*; D005260:Female; D006801:Humans; D008297:Male; D009902:Optic Neuritis / Q000139:chemically induced* / Q000175:diagnosis / Q000628:therapy; D010001:Osteitis Deformans / Q000188:drug therapy; D015663:Osteoporosis, Postmenopausal / Q000188:drug therapy; D012019:Reflex Sympathetic Dystrophy / Q000188:drug therapy; D016896:Treatment Outcome; D014605:Uveitis / Q000139:chemically induced* / Q000175:diagnosis / Q000628:therapy
D050071:Bone Density Conservation Agents; D004164:Diphosphonates